3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Radiation Injuries
1
Neurotoxicity Syndromes
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Esophageal Neoplasms
1
Congenital Abnormalities
1
Colorectal Neoplasms
1
Central Nervous System Neoplasms
1
Brain Neoplasms
1
Interventions
pembrolizumab
28
Cisplatin
24
Oxaliplatin
22
Irinotecan
22
Fluorouracil
22
Capecitabine
20
Leucovorin
17
Paclitaxel
16
Cyclophosphamide
14
Trastuzumab
12
Nivolumab
11
Carboplatin
11
Gemcitabine
10
Bevacizumab
10
Docetaxel
9
fludarabine
8
aldesleukin
8
S 1 (combination)
8
Ramucirumab
7
130-nm albumin-bound paclitaxel
7
atezolizumab
6
Albumin-Bound Paclitaxel
6
Taxes
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
veliparib
4
tislelizumab
4
spartalizumab
4
dehydroftorafur
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Stomach Neoplasms
×
Lithium
×
Clear all
NCT03153280
2025-07-08
Lithium
Cancer Trials Ireland
Phase 1
Terminated
2 enrolled